|
Diabetes, Vol 34, Issue 5 452-461, Copyright © 1985 by American Diabetes Association
Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects
LK Curtiss and JL Witztum
Nonenzymatic posttranslational glucosylation of the free amine of lysine
residues can occur in hyperglycemic diabetic subjects. Using monoclonal
antibodies that specifically bind the reduced conjugate of glucose
covalently bound to the epsilon amine of lysine, glucitollysine, plasma
lipoprotein glucosylation was demonstrated by radioimmunoassays in all
subjects tested. Lipoproteins isolated from the plasma of diabetic subjects
in poor metabolic control contained up to 33-fold increases in
glucitollysine residues/mg of isolated lipoprotein protein, and on an
absolute basis contained between 36 and 383 nmol of glucitollysine in their
total lipoprotein fraction compared with normals, who had a mean of 2.9 +/-
0.06 nmol. The majority of the glucosylated protein in the d less than
1.125 g/ml fraction was present in the triglyceride-rich lipoproteins of
hyperglycemic subjects, whereas the majority of the glucosylated protein in
the d less than 1.125 g/ml fraction of euglycemic subjects was present in
the high-density lipoproteins (HDL). A number of immunochemical approaches
were used to demonstrate that, in diabetic plasma, apo AI, apo AII, apo B,
apo CI, apo E, and albumin were glucosylated. Detailed studies of the
apoproteins of a d less than or equal to 1.019 g/ml lipoprotein fraction
and of an HDL fraction isolated from a hyperglycemic diabetic subject
indicated that glucitollysine-specific antibodies can be used to
preparatively isolate proteins containing glucosylated amino acid residues
so that the extent of glucosylation in specific proteins can be measured.
The results indicate that some of the lysine residues of the apoproteins
can be modified in hyperglycemic diabetic subjects by the covalent
attachment of glucose. The possible significance of these observations is
discussed.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W. Stephens, M. M. Sozen, R. A. Whittall, M. J. Caslake, D. Bedford, J. Acharya, S. J. Hurel, and S. E. Humphries
Three Novel Mutations in the Apolipoprotein E Gene in a Sample of Individuals with Type 2 Diabetes Mellitus
Clin. Chem.,
January 1, 2005;
51(1):
119 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Tannock, K. L. Olin, P. H. R. Barrett, T. N. Wight, and A. Chait
Triglyceride-Rich Lipoproteins from Subjects with Type 2 Diabetes Do Not Demonstrate Increased Binding to Biglycan, a Vascular Proteoglycan
J. Clin. Endocrinol. Metab.,
January 1, 2002;
87(1):
35 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Sobenin, V. V. Tertov, and A. N. Orekhov
Optimization of the assay for sialic acid determination in low density lipoprotein
J. Lipid Res.,
November 1, 1998;
39(11):
2293 - 2299.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Sonmez, S. Suer, T. Ulutin, E. Kokoglu, and N. Ucisik
The Relationship of Various Factors in the Pathogenesis of Atherosclerosis
Clinical and Applied Thrombosis/Hemostasis,
April 1, 1998;
4(2):
105 - 110.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Igau, G. Castro, V. Clavey, C. Slomianny, R. Bresson, P. Drouin, J.-C. Fruchart, and C. Fievet
In Vivo Glucosylated LpA-I Subfraction : Evidence for Structural and Functional Alterations
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1997;
17(11):
2830 - 2836.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M.-X. Fu, J.ús R. Requena, A. J. Jenkins, T. J. Lyons, J. W. Baynes, and S. R. Thorpe
The Advanced Glycation End Product, N[IMAGE]-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
J. Biol. Chem.,
April 26, 1996;
271(17):
9982 - 9986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Palinski, T. Koschinsky, S. W. Butler, E. Miller, H. Vlassara, A. Cerami, and J. L. Witztum
Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits
Arterioscler. Thromb. Vasc. Biol.,
May 1, 1995;
15(5):
571 - 582.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Makino, J. W. Furbee Jr, A. M. Scanu, and G. M. Fless
Effect of Glycation on the Properties of Lipoprotein(a)
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1995;
15(3):
385 - 391.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1985 by the American Diabetes Association.
|
|
| |
|